50 results
Page 2 of 3
10-K/A
EX-31.1
o2i2z2ta5xken6
9 Nov 23
Annual report (amended)
4:05pm
10-K/A
EX-31.2
5majdn hmx22nwp
9 Nov 23
Annual report (amended)
4:05pm
8-K
EX-99.1
1mgkq
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.2
yqfj6sb t7bbwnv9u0
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
vb272qx 7zbn
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
kezi zop18lr3imaz
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
b5buy em2rk
9 May 23
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
7:45am
8-K
EX-3.1
l72pqek s98s2
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
xzij jq9g
9 Nov 22
Shelf registration
4:15pm
S-3
EX-1.2
u2n9k2ip67veb
9 Nov 22
Shelf registration
4:15pm
8-K
EX-99.2
nlvi7 wjnb6ha
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
9bx0640mci 55x
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
DEF 14A
02j33 zp4
26 Apr 22
Definitive proxy
4:05pm